David D. Helsel
SVP, Global Operations and R&D
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $371,345 | $785,625 |
| 2022 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $360,529 | $1,023,657 |
| 2021 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $352,000 | $960,366 |
| 2020 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $349,835 | $769,356 |
| 2019 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $333,945 | $958,262 |
| 2018 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $133,481 | $826,829 |
Executive changes
Earnings-call appearances
No earnings-call appearances recorded yet.